Table 4.

Site of Major Bleeding in Patients With and Without Active Cancer

	All (n=702)	With active cancer (n=323)	Without active cancer (n=379)	P value
All major bleeding	58 (8.3)	42 (13.0)	16 (4.2)	<0.001
Specific site
Gastrointestinal tract bleeding	25 (3.6)	18 (5.6)	7 (1.8)	0.008
Genital bleeding	11 (1.6)	10 (3.1)	1 (0.3)	0.003
Urinary tract bleeding	5 (0.7)	4 (1.2)	1 (0.3)	0.126
Intracranial bleeding	4 (0.6)	2 (0.6)	2 (0.5)	0.873
Respiratory bleeding	3 (0.4)	2 (0.6)	1 (0.3)	0.472
Liver/gall bladder bleeding	2 (0.3)	1 (0.3)	1 (0.3)	0.910
Postoperative bleeding triggered by DOACs	3 (0.4)	2 (0.6)	1 (0.3)	0.472
Others	5 (0.7)	3 (0.9)	2 (0.5)	0.529

Unless indicated otherwise, data are presented as n (%). DOACs, direct oral anticoagulants.